AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Buprenorphine Hydrochloride Equivalent To Buprenorphine in South Africa

9 products registered with SAHPRA 6 active

Brand / ProductReg. No.HolderStatusExpires
SOBRIXA 2,0 mg600/34/0352Adcock Ingram Critical Care (Pty) Ltdactive18 Feb 2030
SOBRIXA 8,0 mg60/34/0353Adcock Ingram Critical Care (Pty) Ltdactive18 Feb 2030
SOBRIXA 0,4 mg60/34/0351Adcock Ingram Critical Care (Pty) Ltdactive18 Feb 2030
SUBUTEX SUBLINGUAL 0,4 mg33/34/0377Adcock Ingram Critical Care (Pty) Ltdsuspended9 Mar 2026
SUBUTEX SUBLINGUAL 2,0 mg33/34/0378Adcock Ingram Critical Care (Pty) Ltdsuspended9 Mar 2026
SUBUTEX SUBLINGUAL 8,0 mg33/34/0379Adcock Ingram Critical Care (Pty) Ltdsuspended9 Mar 2026
TEmgESIC 2 mlL/2.9/0158Reckitt Benckinser Pharmaceuticals (Pty) Ltdactive1 Jan 1900
TEmgESIC SUBLINGUAL TABLETSS/2.7/327Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900
TEmgESIC 1 mlL/2.9/157Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900

Buprenorphine Hydrochloride Equivalent To BuprenorphineSAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Buprenorphine Hydrochloride Equivalent To Buprenorphine, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Buprenorphine Hydrochloride Equivalent To Buprenorphine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.